Skip to content

Biomarker Screening for Antenatal Depression: A Study Based on Metabolomics Analysis

Biomarker Screening for Antenatal Depression: A Study Based on Metabolomics Analysis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016230
Enrollment
Unknown
Registered
2018-05-21
Start date
2018-05-22
Completion date
Unknown
Last updated
2018-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

antenatal Depression

Interventions

Prenata depression group:Depression diagnosis
No prenatal depression group:Depression diagnosis

Sponsors

Department of Anesthesiology, the Second Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1) Aged 20 to 40 years old; 2) ASA I ~ II; 3) single-term full-term pregnancy; 4) Willing to participate in this study and signing informed consent

Exclusion criteria

Exclusion criteria: 1) History of mental illness or treatment with psychotropic substances; 2) known history of depression before pregnancy; 3) History of drug abuse, alcohol or opioid abuse; 4) Combining medical diseases such as heart, brain, liver, kidney, and hematopoietic system; 5) For any reason, research cannot be coordinated.

Design outcomes

Primary

MeasureTime frame
Metabolites;

Countries

China

Contacts

Public ContactHong LI

The Second Affiliated Hospital of Army Medical University

472217836@qq.com+86 02368774997

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 2, 2026